OQ
LIVE

Serial Number

79452174

Owner

Otsuka Pharmaceutical Co., Ltd.

Filing Date

Mar 12, 2026

Add to watchlist:

No watchlists yet
View on USPTO

OQ Trademark

Serial Number: 79452174

OQ is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on March 12, 2026. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (571 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

Trademark Details

Filing Date

March 12, 2026

Registration Date

Not Registered

Published for Opposition

August 11, 2026

Goods & Services

Pharmaceutical preparations for the treatment and prevention of central nervous system diseases and disorders; pharmaceutical preparations for the treatment and prevention of cancer; pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of kidney diseases and disorders; pharmaceutical preparations for the treatment and prevention of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment and prevention of infectious diseases; pharmaceutical preparations for the treatment and prevention of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment and prevention of dermatological diseases and disorders; pharmaceutical preparations for the treatment and prevention of respiratory diseases and disorders; pharmaceutical preparations for the treatment and prevention of autoimmune diseases and disorders; pharmaceutical preparations for use as a preparatory regimen in connection with bone marrow transplants; pharmaceutical preparations for the treatment and prevention of metabolic diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases and disorders; pharmaceutical preparations for inhibiting blood platelet aggregation

Filing History

PUBLISHED FOR OPPOSITION
Aug 11, 2026 PUBO
NOTICE OF PUBLICATION
Aug 5, 2026 NPUB
NEW REPRESENTATIVE AT IB RECEIVED
Jul 23, 2026 NREP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 14, 2026 CNSA
ASSIGNED TO EXAMINER
Jul 13, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Jul 1, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 1, 2026 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jun 29, 2026 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 18, 2026 REPR